Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»

The Scientific Advisory Board, chaired by Professor G. R. Galstyan (cochair - A.V. Zilov), met in Moscow on 19 June 2018 to discuss the possibilities of improving the results of diabetes mellitus (DM) treatment by considering glycaemic variability (GV) as an additional criterion for effective glycae...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mikhail B. Antsiferov, Gagik R. Galstyan, Alexey V. Zilov, Alexander Y. Mayorov, Tatyana N. Markova, Nikolay A. Demidov, Olga M. Koteshkova, Dmitry N. Laptev, Alisa V. Vitebskaya
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2019
Materias:
Acceso en línea:https://doaj.org/article/febf407be8244615888799b8d6451e5f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:febf407be8244615888799b8d6451e5f
record_format dspace
spelling oai:doaj.org-article:febf407be8244615888799b8d6451e5f2021-11-14T09:00:22ZResolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»2072-03512072-037810.14341/DM10227https://doaj.org/article/febf407be8244615888799b8d6451e5f2019-08-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/10227https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The Scientific Advisory Board, chaired by Professor G. R. Galstyan (cochair - A.V. Zilov), met in Moscow on 19 June 2018 to discuss the possibilities of improving the results of diabetes mellitus (DM) treatment by considering glycaemic variability (GV) as an additional criterion for effective glycaemic control (especially in patients receiving insulin therapy) and as one of the goals of treatment in patients with unstable glycaemia. The purpose of the working meeting was to develop a strategy for the introduction of GV as a predictor and as an additional criterion for assessing the effectiveness and safety of hypoglycaemic therapy to improve the pharmacotherapy of diabetes and reduce cardiovascular and total mortality. The aims of the working meeting were to conduct a comprehensive data analysis of the relationship between GV and hypoglycaemia; to gather and analyse published data and the experience of decrease in GV and improved outcomes of diabetes against the background of different types of insulin therapy; to compare existing methods of glycaemia monitoring and GV assessment and examine their validity and availability in real practice in the context of limited budget and to analyse the informativeness and clinical and prognostic significance of various parameters of GV assessment and to determine their reasonable ‘minimum’ for a comprehensive assessment of GV as a criterion for evaluating the effectiveness of DM treatment and the predictors of negative diabetes outcomes. The following reports were presented during the discussion: ‘Glycemic variability: clinical and prognostic value. Types of glycemic variability’ (Candidate of Medical Sciences, assistant Professor Zilov A.V.); ‘Methods of assessment of variability of glycemia in clinical trials and routine practice’ (PhD, Professor Markova T. N.); ‘Current international and national recommendations on glycemic monitoring’ (PhD, Professor Galstyan G. R.) and ‘Peculiarities of glycemic variability and its evaluation among children and adolescents’ (Candidate of Medical Sciences Vitebskaya A.V.).Mikhail B. AntsiferovGagik R. GalstyanAlexey V. ZilovAlexander Y. MayorovTatyana N. MarkovaNikolay A. DemidovOlga M. KoteshkovaDmitry N. LaptevAlisa V. VitebskayaEndocrinology Research Centrearticlevariability of glycemiafasting plasma glucosepostprandial glycemiahba1ccoefficient of variabilitycontinuous glucose monitoring (cgm)self-measured blood glucosediabetes mellitusinsulin degludecNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 22, Iss 3, Pp 281-288 (2019)
institution DOAJ
collection DOAJ
language EN
RU
topic variability of glycemia
fasting plasma glucose
postprandial glycemia
hba1c
coefficient of variability
continuous glucose monitoring (cgm)
self-measured blood glucose
diabetes mellitus
insulin degludec
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle variability of glycemia
fasting plasma glucose
postprandial glycemia
hba1c
coefficient of variability
continuous glucose monitoring (cgm)
self-measured blood glucose
diabetes mellitus
insulin degludec
Nutritional diseases. Deficiency diseases
RC620-627
Mikhail B. Antsiferov
Gagik R. Galstyan
Alexey V. Zilov
Alexander Y. Mayorov
Tatyana N. Markova
Nikolay A. Demidov
Olga M. Koteshkova
Dmitry N. Laptev
Alisa V. Vitebskaya
Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
description The Scientific Advisory Board, chaired by Professor G. R. Galstyan (cochair - A.V. Zilov), met in Moscow on 19 June 2018 to discuss the possibilities of improving the results of diabetes mellitus (DM) treatment by considering glycaemic variability (GV) as an additional criterion for effective glycaemic control (especially in patients receiving insulin therapy) and as one of the goals of treatment in patients with unstable glycaemia. The purpose of the working meeting was to develop a strategy for the introduction of GV as a predictor and as an additional criterion for assessing the effectiveness and safety of hypoglycaemic therapy to improve the pharmacotherapy of diabetes and reduce cardiovascular and total mortality. The aims of the working meeting were to conduct a comprehensive data analysis of the relationship between GV and hypoglycaemia; to gather and analyse published data and the experience of decrease in GV and improved outcomes of diabetes against the background of different types of insulin therapy; to compare existing methods of glycaemia monitoring and GV assessment and examine their validity and availability in real practice in the context of limited budget and to analyse the informativeness and clinical and prognostic significance of various parameters of GV assessment and to determine their reasonable ‘minimum’ for a comprehensive assessment of GV as a criterion for evaluating the effectiveness of DM treatment and the predictors of negative diabetes outcomes. The following reports were presented during the discussion: ‘Glycemic variability: clinical and prognostic value. Types of glycemic variability’ (Candidate of Medical Sciences, assistant Professor Zilov A.V.); ‘Methods of assessment of variability of glycemia in clinical trials and routine practice’ (PhD, Professor Markova T. N.); ‘Current international and national recommendations on glycemic monitoring’ (PhD, Professor Galstyan G. R.) and ‘Peculiarities of glycemic variability and its evaluation among children and adolescents’ (Candidate of Medical Sciences Vitebskaya A.V.).
format article
author Mikhail B. Antsiferov
Gagik R. Galstyan
Alexey V. Zilov
Alexander Y. Mayorov
Tatyana N. Markova
Nikolay A. Demidov
Olga M. Koteshkova
Dmitry N. Laptev
Alisa V. Vitebskaya
author_facet Mikhail B. Antsiferov
Gagik R. Galstyan
Alexey V. Zilov
Alexander Y. Mayorov
Tatyana N. Markova
Nikolay A. Demidov
Olga M. Koteshkova
Dmitry N. Laptev
Alisa V. Vitebskaya
author_sort Mikhail B. Antsiferov
title Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
title_short Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
title_full Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
title_fullStr Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
title_full_unstemmed Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
title_sort resolution on the results of the first working meeting of the scientific advisory board «actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
publisher Endocrinology Research Centre
publishDate 2019
url https://doaj.org/article/febf407be8244615888799b8d6451e5f
work_keys_str_mv AT mikhailbantsiferov resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
AT gagikrgalstyan resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
AT alexeyvzilov resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
AT alexanderymayorov resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
AT tatyananmarkova resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
AT nikolayademidov resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
AT olgamkoteshkova resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
AT dmitrynlaptev resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
AT alisavvitebskaya resolutionontheresultsofthefirstworkingmeetingofthescientificadvisoryboardactualproblemsofglycemicvariabilityasanewcriterionofglycemiccontrolandsafetyofdiabetestherapy
_version_ 1718429504997687296